GemmaBio, a company founded by gene therapy pioneer Jim Wilson, has raised $34 million in seed funding to try and resuscitate the floundering gene therapy field.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
Federal judges have blocked two Florida wellness centers from using Novo Nordisk’s trademark to market compounded drugs containing its diabetes and weight loss blockbuster semaglutide.
Adding salt to food, even just sometimes, was significantly associated with a higher risk for chronic kidney disease (CKD), a large prospective cohort study showed.
What You Should Know: –Texas A&M Health and BurstIQ, a leader in advanced data management, today announced a partnership to leverage LifeGraph®, a graph-powered, end-to-end